CytoMed Therapeutics Limited GDTC · SEC Filings

website

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, f...

Price0.859

Market Cap10.26 M

Float5.26 M

CountrySG

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 31, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 28, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 22, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

May 1, 2023

News

TYPE

HEADLINE

FILED AT

6-K

CytoMed Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notification

Oct 9, 2026

6-K

CytoMed Therapeutics Reports Unaudited Financial Results for the Six Months Ended June 30, 2026

Sep 30, 2026

6-K

CytoMed Therapeutics Chairman Announces Share Purchase Plan and Subsidiary Investment

Jun 23, 2026

6-K

CytoMed Therapeutics Limited Announces Results of 2026 Annual General Meeting

Jun 3, 2026

6-K

CytoMed Therapeutics Chairman Acquires 112,000 Ordinary Shares

May 15, 2026

6-K

CytoMed Therapeutics Subsidiary Rebrands to CytoMed International Pte. Ltd.

May 11, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

August 2025 ATM | Amount sold to date: $0 | Float: 5,178,181

Aug 18, 2025

424B4

OFFERING | Shares amount: 2,412,369 | Share price: $4.00 | Offering amount: $9,649,476.00

Apr 17, 2023

Registrations

TYPE

HEADLINE

FILED AT

F-3

June 2025 SHELF | Amount sold to date: $0

Jun 13, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 6, 2025

FWP

Registration

Mar 31, 2023

8-A12B

Registration

Mar 30, 2023

F-1/A

INITIAL REGISTRATION FOR OFFERING EFFECTIVE

Mar 30, 2023

F-1/A

INITIAL REGISTRATION FOR OFFERING | Shares amount: 2,412,369 | Share price: $4.50 EFFECTIVE

Mar 27, 2023

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 24, 2025

CORRESP

Form CORRESP - Correspondence

Jun 20, 2025

LETTER

Form UPLOAD - SEC-generated letter

Jun 18, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 3, 2023

CORRESP

Form CORRESP - Correspondence

Mar 31, 2023

CORRESP

Form CORRESP - Correspondence

Mar 31, 2023